Expression Therapeutics
Manufacturing · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1860 Montreal Rd, Tucker, Georgia, 30084...Phone Number
(678) 278-1140Revenue
<$5 MillionIndustry
About Expression Therapeutics
Expression Therapeutics is a clinical-stage biotechnology company focused on developing curative gene therapies for hemophilia A and advanced cell therapies for neuroendocrine tumors (NETs). Utilizing proprietary AI-based technologies, the company operates a state-of-the-art GMP manufacturing facility in Cincinnati, Ohio. Their lead product, ET3, is a next-generation gene therapy aimed at providing long-lasting protection for hemophilia A patients, while their ADEPT-STAR platform targets NETs with innovative cell and gene therapy approaches. The company is dedicated to controlling the entire process from discovery to delivery, ensuring high-quality therapeutic development.Explore more
Expression Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Expression Therapeutics
Compare insights from companies similar to Expression Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Expression Therapeutics Tech Stack
A closer look at the technologies used by Expression Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Expression Therapeutics
Sign Up For FreeTo access detailed company insights
Expression Therapeutics is a clinical-stage biotechnology company focused on developing curative gene therapies for hemophilia A and advanced cell therapies for neuroendocrine tumors (NETs). Utilizing proprietary AI-based technologies, the company operates a state-of-the-art GMP manufacturing facility in Cincinnati, Ohio. Their lead product, ET3, i... Read More
